• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撒哈拉以南非洲地区丙型肝炎病毒即时检测诊断的质量保证

Quality Assurance for Hepatitis C Virus Point-of-Care Diagnostics in Sub-Saharan Africa.

作者信息

Duah Evans, Mathebula Evans Mantiri, Mashamba-Thompson Tivani

机构信息

Faculty of Health Science, School of Health Systems and Public Health, University of Pretoria, Pretoria 0002, South Africa.

出版信息

Diagnostics (Basel). 2023 Feb 12;13(4):684. doi: 10.3390/diagnostics13040684.

DOI:10.3390/diagnostics13040684
PMID:36832172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9955859/
Abstract

As part of a multinational study to evaluate the Bioline Hepatitis C virus (HCV) point-of-care (POC) testing in sub-Saharan Africa (SSA), this narrative review summarises regulatory standards and quality indicators for validating and approving HCV clinical diagnostics. In addition, this review also provides a summary of their diagnostic evaluations using the REASSURED criteria as the benchmark and its implications on the WHO HCV elimination goals 2030.

摘要

作为一项评估撒哈拉以南非洲(SSA)地区Bioline丙型肝炎病毒(HCV)即时检测(POC)的跨国研究的一部分,本叙述性综述总结了用于验证和批准HCV临床诊断的监管标准和质量指标。此外,本综述还以REASSURED标准为基准,总结了它们的诊断评估及其对世界卫生组织2030年HCV消除目标的影响。

相似文献

1
Quality Assurance for Hepatitis C Virus Point-of-Care Diagnostics in Sub-Saharan Africa.撒哈拉以南非洲地区丙型肝炎病毒即时检测诊断的质量保证
Diagnostics (Basel). 2023 Feb 12;13(4):684. doi: 10.3390/diagnostics13040684.
2
REASSURED diagnostics at point-of-care in sub-Saharan Africa: A scoping review.撒哈拉以南非洲即时医疗点的安心诊断:一项范围综述。
PLOS Glob Public Health. 2023 Jun 5;3(6):e0001443. doi: 10.1371/journal.pgph.0001443. eCollection 2023.
3
Point-of-care diagnostics for infection and antimicrobial resistance in sub-Saharan Africa: A narrative review.撒哈拉以南非洲地区感染与抗菌药物耐药性的即时诊断:一项叙述性综述。
Int J Infect Dis. 2024 May;142:106907. doi: 10.1016/j.ijid.2023.11.027. Epub 2023 Dec 21.
4
Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.马拉维住院患者中乙型和丙型肝炎病毒感染率及与艾滋病毒的合并感染情况
J Infect. 2008 Jul;57(1):72-7. doi: 10.1016/j.jinf.2008.05.004. Epub 2008 Jun 13.
5
Lessons Learned From Global Hepatitis C Elimination Programs.从全球丙型肝炎消除计划中吸取的经验教训。
J Infect Dis. 2024 May 8;229(Supplement_3):S334-S341. doi: 10.1093/infdis/jiad198.
6
The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination.迫切需要实施即时 HCV RNA 检测以支持消除。
Clin Infect Dis. 2024 May 15;78(5):1235-1239. doi: 10.1093/cid/ciad503.
7
A Synthesis of Hepatitis C prevalence estimates in Sub-Saharan Africa: 2000-2013.撒哈拉以南非洲地区丙型肝炎患病率估计值的综合分析:2000 - 2013年
BMC Infect Dis. 2016 Jun 13;16:283. doi: 10.1186/s12879-016-1584-1.
8
Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Mobile-Linked Point-of-Care Diagnostics in Sub-Saharan Africa.撒哈拉以南非洲地区移动连接即时诊断诊断准确性的系统评价与荟萃分析
Diagnostics (Basel). 2021 Jun 12;11(6):1081. doi: 10.3390/diagnostics11061081.
9
Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination.以消除丙型肝炎为目标的基于护理点的丙型肝炎检测和治疗策略:为丙型肝炎防治和成瘾中心就诊者提供服务。
J Viral Hepat. 2022 Mar;29(3):227-230. doi: 10.1111/jvh.13634. Epub 2021 Nov 29.
10
Clinical utility of the 'Determine HBsAg' Point-of-Care Test for Diagnosis of Hepatitis B Surface Antigen in Africa.“Determine HBsAg”即时检验在非洲诊断乙型肝炎表面抗原中的临床应用
Expert Rev Mol Diagn. 2022 May;22(5):497-505. doi: 10.1080/14737159.2022.2076595. Epub 2022 Jul 12.

引用本文的文献

1
Assessing user experience with the Bioline™ HCV point-of-care test in primary healthcare settings: a mixed-methods study.在基层医疗环境中评估用户对Bioline™丙型肝炎即时检测的体验:一项混合方法研究。
BMC Health Serv Res. 2025 Apr 1;25(1):484. doi: 10.1186/s12913-025-12634-8.
2
REASSURED evaluation of the Bioline HCV point-of-care testing for diagnosing hepatitis C virus infection in primary healthcare settings of Ghana: a study protocol.加纳基层医疗保健环境中用于诊断丙型肝炎病毒感染的 Bioline HCV 即时检测的放心评估:研究方案。
BMJ Open. 2024 Nov 9;14(11):e082416. doi: 10.1136/bmjopen-2023-082416.

本文引用的文献

1
GeneXpert rollout in three high-burden tuberculosis countries in Africa: A review of pulmonary tuberculosis diagnosis and outcomes from 2001 to 2019.非洲三个结核病高负担国家的GeneXpert推广:2001年至2019年肺结核诊断与结果综述
Afr J Lab Med. 2022 Aug 30;11(1):1811. doi: 10.4102/ajlm.v11i1.1811. eCollection 2022.
2
HCV Self-Testing to Expand Testing: A Pilot Among Men Who Have Sex With Men in China.HCV 自我检测以扩大检测:中国男男性行为者中的一项试点。
Front Public Health. 2022 May 31;10:903747. doi: 10.3389/fpubh.2022.903747. eCollection 2022.
3
Diagnostic Accuracy of Point-of-Care HCV Viral Load Assays for HCV Diagnosis: A Systematic Review and Meta-Analysis.即时检测丙型肝炎病毒载量检测法用于丙型肝炎诊断的诊断准确性:一项系统评价和荟萃分析
Diagnostics (Basel). 2022 May 18;12(5):1255. doi: 10.3390/diagnostics12051255.
4
Hepatitis C virus (HCV) infection among patients with sickle cell disease at the Korle-Bu teaching hospital.科勒布教学医院镰状细胞病患者中的丙型肝炎病毒 (HCV) 感染。
Virol J. 2022 Apr 22;19(1):73. doi: 10.1186/s12985-022-01797-z.
5
Evaluation of hepatitis C virus antibody assay using dried blood spot samples.应用干血斑样本评估丙型肝炎病毒抗体检测。
Sci Rep. 2022 Mar 8;12(1):3763. doi: 10.1038/s41598-022-07821-0.
6
REASSURED Multiplex Diagnostics: A Critical Review and Forecast.安心多重诊断:批判性回顾与预测。
Biosensors (Basel). 2022 Feb 16;12(2):124. doi: 10.3390/bios12020124.
7
A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmission.马拉维布兰太尔的丙型肝炎临床和分子流行病学调查表明存在一种历史传播机制。
J Viral Hepat. 2022 Apr;29(4):252-262. doi: 10.1111/jvh.13646. Epub 2022 Feb 9.
8
Performance of HCV Antigen Testing for the Diagnosis and Monitoring of Antiviral Treatment: A Systematic Review and Meta-Analysis.丙型肝炎病毒抗原检测在抗病毒治疗的诊断和监测中的应用:系统评价和荟萃分析。
Biomed Res Int. 2022 Jan 4;2022:7348755. doi: 10.1155/2022/7348755. eCollection 2022.
9
Cost-effectiveness of chronic hepatitis C screening and treatment.慢性丙型肝炎筛查与治疗的成本效益
Clin Mol Hepatol. 2022 Apr;28(2):164-173. doi: 10.3350/cmh.2021.0193. Epub 2021 Dec 27.
10
Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator.使用 Hep C Testing Calculator 评估格鲁吉亚丙型肝炎检测途径的成本效益。
Sci Rep. 2021 Nov 1;11(1):21382. doi: 10.1038/s41598-021-00362-y.